Viza rejimini liberallashtirishning kiruvchi turizmga ta'sirini baholash: gravitatsiya modeli va mashinali o'qitish uyg'unligi
AGROBUSINESS, SCIENCE AND TECHNOLOGY · 05.11.2026 · 4 (11)
DOI: 10.68372/3f140k68 ↗Kurz gefasst
Fachartikel in der Zeitschrift AGROBUSINESS, SCIENCE AND TECHNOLOGY, online erschienen am 05.11.2026. Verfasst von Akbar Mahmudovich Jumayev.
Abstract (Originalsprache)
The article assesses the determinants of inbound tourist flows to Uzbekistan and the impact of the 2018–2019 visa liberalization reform. A “Tourist Attractiveness Factors Model” is proposed that combines a gravity model, an event study and machine learning algorithms. The gravity model is estimated by Poisson pseudo-maximum likelihood using official country-level data for 2014–2025. Tourist flows are driven by the population (elasticity 0.83), income (0.89) and distance (−1.59) of origin countries; flows from neighbouring countries are 7.5 times higher and from CIS countries 11.4 times higher. The visa effect built up over several years and in 2022–2024 corresponded to a 102–178% increase in flows. XGBoost achieved the highest out-of-sample accuracy (R² = 0.850). The potential of the Indian, Pakistani and Bangladeshi markets is found to be largely untapped.
Zitieren
APA
Jumayev, A. M. (2026). Viza rejimini liberallashtirishning kiruvchi turizmga ta'sirini baholash: gravitatsiya modeli va mashinali o'qitish uyg'unligi. AGROBUSINESS, SCIENCE AND TECHNOLOGY, 4(11). https://doi.org/10.68372/3f140k68
Vancouver
Jumayev AM. Viza rejimini liberallashtirishning kiruvchi turizmga ta'sirini baholash: gravitatsiya modeli va mashinali o'qitish uyg'unligi. AGROBUSINESS, SCIENCE AND TECHNOLOGY. 2026;4(11). doi:10.68372/3f140k68
BibTeX
@article{Jumayev2026,
author = {Jumayev, Akbar Mahmudovich},
title = {Viza rejimini liberallashtirishning kiruvchi turizmga ta'sirini baholash: gravitatsiya modeli va mashinali o'qitish uyg'unligi},
journal = {AGROBUSINESS, SCIENCE AND TECHNOLOGY},
year = {2026},
volume = {4},
number = {11},
doi = {10.68372/3f140k68}
}
EUVIMED